Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05837481 · ClinicalTrials.gov registry record · NA
Guided Meditation to Decrease Perioperative Anxiety and Increase Patient Intraoperative Compliance in Vascular Surgery
A NA study of Peripheral Vascular Disease, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 4
- Study locations
NCT05837481 is a NA study of Peripheral Vascular Disease that has completed, run by Massachusetts General Hospital. The registered enrollment target is 30 participants, below the 281-participant average among 25 other Peripheral Vascular Disease trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT05837481, a NA study of Peripheral Vascular Disease, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary purpose of this clinical trial is to test the feasibility of implementing a perioperative guided meditation program for patients undergoing peripheral vascular interventions that are performed under procedural sedation and analgesia.
Conditions Studied
Interventions
- BEHAVIORAL Meditation
Study Locations (4)
Massachusetts
- Massachusetts General Hospital - Boston
- Newton Wellesley Hospital - Newton
- Salem Hospital - Salem
New Hampshire
- Southern New Hampshire Hospital - Nashua
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05837481
The ClinicalTrials.gov registry entry for NCT05837481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 25 other Peripheral Vascular Disease trials with a reported enrollment target (89% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Vascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Meditation is the first listed.
NCT05837481 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05837481 about?
NCT05837481 is a clinical study titled "Guided Meditation to Decrease Perioperative Anxiety and Increase Patient Intraoperative Compliance in Vascular Surgery". The primary purpose of this clinical trial is to test the feasibility of implementing a perioperative guided meditation program for patients undergoing peripheral vascular interventions that are performed under procedural sedation and analgesia.
What is the current status of trial NCT05837481?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-07-11. Estimated completion is 2024-04-01.
What conditions does trial NCT05837481 study?
This clinical trial studies the following conditions: Peripheral Vascular Disease.
What interventions are being tested in trial NCT05837481?
The interventions under investigation include: Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05837481?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05837481 being conducted?
This trial has 4 study locations across Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Vascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Far Red Light to Improve Functioning in PAD
RECRUITING · NA
-
Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
RECRUITING · NA
-
ENhancing Exercise with LIGHT to Improve Functioning in PAD
RECRUITING · NA
-
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
COMPLETED · NA
-
A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery
COMPLETED · NA
-
JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.